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Developmental changes in rat renal 1113-hydroxysteroid dehydroge-
nase. 1 1/3-hydroxysteroid dehydrogenase (1 113-OHSD) transforms en-
dogenous glucocorticoids to their respective "biologically inert" 11-
dehydro derivatives. A decrease in enzyme activity allows
glucocorticoids to induce mineralocorticoid-like renal sodium retention.
Since positive sodium balance is required for optimum growth in the
newborn, we hypothesized that renal 1 I/3-OHSD activity would be low
in the postnatal period, a time of active growth. To test this, incubations
with corticosterone were carried out using minces or homogenates
prepared from kidneys of newborn, 8-day-old, and mature Spague-
Dawley rats. 1 l/3-OHSD activity in renal minces, assessed by the
percent of corticosterone (10—8 M) transformed to 1 1-dehydrocortico-
sterone (compound A), was significantly lower in the newborn kidney
(newborn 45.7 3.8%, 8 day 70.2 3.8%, and adult 73.4 3.1%, P <
0.001 1 vs. 8 day). Parallel studies were conducted using an antibody
directed against liver I 1/3-OHSD counter stained with immunofluores-
cent labeled IgO. Kidneys from mature rats were brightly stained at S2
and S3 segments of proximal tubules. In contrast, staining was barely
detectable in kidneys from the newborn and 8-day-old rats. When
enzyme kinetics were examined in kidney homogenates (average pro-
tein concentration 2.5 mg/mI) in the presence of 200 JM NADP, the
apparent Km for corticosterone in the adult was 4,42 x 106 M with a
corresponding Vmax of 1.33 x iO mollminlmg protein, while the
apparent Km for corticosterone in the newborn was calculated to be
12.8 x 10_8 M with a maX of2.08 x 10- mollmin/mg protein. Thus
1 1f3-OHSD activity appears diminished in the newborn kidney second-
ary to a decrease in the renal content of the enzyme and the lower
apparent Km and max for corticosterone.
Positive sodium balance is essential for optimum postnatal
growth and development [1]. Renal conservation of sodium
needed for growth is achieved in spite of a limited renal tubular
response to antinatriuretic hormones including aldosterone
early in postnatal life [2, 3]. The enzyme 1 1/3-hydroxysteroid
dehydrogenase (1 1/3-OHSD) may be among the various factors
involved with renal sodium retention early in the postnatal
period. This intracellular enzyme, present principally in liver
and kidney, metabolizes circulating endogenous glucocorti-
colds to their respective "biologically inert" 1 1-dehydro deriv-
atives [4—7]. The 1 1-dehydro end-product of the enzyme does
not bind to the mineralocorticoid receptor [6]. This is of
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importance since mineralocorticoid and glucocorticoids are
capable of binding to mineralocorticoid receptors with equiva-
lent affinity in vitro [8]. When enzyme activity is decreased
either because of congenital deficiency or chemical inhibition,
endogenous circulating glucocorticoids exhibit mineralocorti-
coid-like activity, including renal sodium retention [7, 9, 10].
Given the need for positive sodium balance in the developing
newborn, we hypothesized that renal cortex from newborn
animals exhibits lower 1 l/3-OHSD activity relative to the adult.
A difference in enzyme activity might be explained by a lower
intracellular content of 11/3-OHSD, by a change in enzyme
kinetics, and/or by the presence of a circulating inhibitor. Data
generated from the present studies demonstrate a decrease in
enzyme activity which can be accounted for both by a reduced
intracellular enzyme content, and developmental differences in
the apparent Km (Michaelis constant) and max (maximal
velocity) for 1 l/3-OHSD.
Methods
Tritiated corticosterone was obtained from New England
Nuclear (Boston, Massachusetts, USA). Non-radioactive cor-
ticosterone was purchased from Sigma Corporation (St. Louis,
Missouri, USA), and the il-dehydrocorticosterone used as a
standard was a gift from Professor T.H. Kirk, MRC Steroid
Collection (London, UK). The kidneys were excised from
one-day-old, eight-day-old, and mature adrenally intact Spra-
gue Dawley rats immediately following sacrifice. Prior to sac-
rifice, all animals had been given free access to food and water.
The kidneys were then placed in an iced mammalian Ringer's
solution at pH 7.4. In selected experiments, the renal cortex
was minced and then transferred into pre-oxygenated mamma-
lian Ringer's solution containing labeled corticosterone. The
tissue minces were then incubated in a water bath adjusted to
37°C. In separate studies, tissue homogenates were prepared
from renal cortex by sonicating samples in a sodium phosphate
solution containing protease inhibitors, leupeptin and aprote-
nm. The cofactor, NAD or NADP was added to the homoge-
nate solution, as indicated in the Results. Corticosterone was
the substrate used in all studies.
At the completion of an incubation, the reaction was stopped
by adding 2 ml of methanol to the bathing medium. The tissue
minces or homogenate samples then were centrifuged at 3,600
rpm for two minutes. Aliquots of the supernatant containing the
Fig. 1. A representative HPLC demonstrating
the generation of Il-dehydrocorticosterone
(compound A) from corticosterone (compound
B) by 1113-OHSD in renal cortex from I day, 8
day and mature rats. Incubations were
performed for 60 minutes with a bath
corticosterone concentration of i0- M.
tritiated corticosterone and its metabolites were then taken for
HPLC analysis. The metabolites of the corticosterone were
separated using HPLC on a Dupont Zorbax C8 column eluded
at 44CC at a flow rate of 1 ml/min using 45% methanol for 30
minutes and increasing linearly to 100% methanol over an
additional 15 minutes. The glucocorticoid and its metabolites
were identified by monitoring radioactivity on line with a
Berthold LB 504 detection system coupled to an NEC APC 4
computer. The various steroids were identified by HPLC and
compared to the retention times of known standards. Where
appropriate, moles of 1 1-dehydrocorticosterone were normal-
ized for the protein in each sample. Proteins were analyzed
using a Bradford assay (Bio-Rad Laboratories, Richmond,
California, USA).
In separate studies, renal cortex was flash frozen in isopen-
tane liquid nitrogen for immunofluorescence localization of
1 1/3-OHSD. Four to 6 micrometer frozen sections of kidney
were incubated in a 0.02 M phosphate-buffered saline solution
adjusted to pH 7.35 which contained antibody directed against
1 1/3-OHSD. The rabbit-derived polyclonal antibody used for
the histochemical identification of 1 113-OHSD was prepared
from rat liver and was provided by Dr. Carl Monder (New
York, New York, USA). Results using this antibody prepara-
tion have been previously published [11, 12]. The antibody was
diluted 1:10 and the sections were incubated for 30 minutes at
room temperature. After the incubation with the primary anti-
body, sections were exposed to fluorescent isothiocyanate
labeled goat-antirabbit immunoglobulin 0, diluted 1:10 in the
phosphate buffered saline for an additional 30 minutes at room
temperature. Sections were washed three times with cold
phosphate-buffered saline between the antibody incubations.
Negative controls were run and consisted of renal cortex
incubated with non-immune rabbit serum in place of the anti
1 113-OHSD antibody. Tubular segments within the renal cortex
were identified by light microscopy.
Where appropriate the data were expressed as the mean
standard error and analyzed statistically with Student's t-test.
Significance was determined at P <0.05.
Results
During the first eight days of life, the rats underwent rapid
growth. The average weight of the rats increased from 5.4
grams at birth to 15.3 grams by day 8. In initial studies, renal
minces from newborn, 8-day-old, and mature Sprague-Dawley
rats were incubated with 3H-corticosterone 108 M for 60
minutes. 1 lp-OHSD activity, assessed by the formation of
1 1-dehydrocorticosterone (compound A), was less in the kid-
neys from the youngest animals as seen in a representative
HPLC from each group (Fig. 1). When the individual groups
were analyzed, 1 1j3-OHSD activity in renal minces from the
newborn transformed 45.7 3.8% of the available corticoste-
rone during the incubation (N = 8), while similarly prepared
renal minces from 8-day-old litter mates transformed 70.2
3.8% of the corticosterone to compound A (N = 10; 1 day vs. 8
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Fig. 2. A photomicrograph of renal cortex from newborn and mature rats exposed to antibody directed against 1113-OHSD and counter stained
with fluorescence labeled IgG. Renal cortex from the newborn rat stain showed minimal staining (A). In contrast, renal cortex from mature rats
displayed bright staining of S2 and S3 segments of proximal tubules (B).
day, P < 0.001). Enzyme activity in the renal minces from adult
kidney was similar to that observed in the 8-day-old; 73.4
3.1% of the corticosterone was metabolized to compound A (N
= 11). The protein concentrations of the mince preparations
averaged 1.16, 1.68, and 1.96 mg/mI, respectively. Thus, the
decrease in 1 113-OHSD activity noted in the newborn correlated
with a general decrease in protein concentration within the
individual samples.
In studies using a polyclonal antibody directed against 11/3-
OHSD from rat liver and immunofluorescence techniques, renal
cortical tissue from adult rats primarily stains S2 and S3
segments of proximal tubules. The isoform of 1 1/3-OHSD
present in the mineralocorticoid selective cortical collecting
duct does not react to this antibody. When selected samples of
renal tissue from newborn, 8-day-old and mature rats were
examined, a distinct decrease in the amount of fluorescence was
noted in the newborn as compared to the adult (Fig. 2). The
minimal staining in renal tissue from newborn and 8-day-old
animals was consistent with a diminished amount of enzyme
within renal proximal tubule epithelial cells.
Additional studies of enzyme kinetics were performed on
homogenates prepared from rat kidney. The protein content in
all these studies was comparable averaging 2.5 0.2 mg/mI
(mean SE). In both the newborn and the adult, 1l13-OHSD
activity using corticosterone 10—8 M was extremely rapid and
linear between 3 and 10 minutes (Fig. 3). In experiments where
the cofactor concentration was varied from 0 to 200 /.LM, both
NAD and NADP were equally effective in supporting en-
zyme activity in the newborn and adult. In determining the
apparent Km for corticosterone, renal homogenates were incu-
bated for 10 minutes with 200 M NADP and corticosterone in
concentrations that ranged from 10—8 M to 10_6 M. From
Lineweaver-Burk plots, the apparent Km in the newborn was
calculated to be 12.8 x lO_8 M with a Vmax of 2.08 x
mollmin/mg protein, while the apparent Km for corticosterone
in the mature kidney was 4.42 x l0_6 M with a corresponding
"maxof 1.33 x 1O mollmin/mg protein (Fig. 4). When studies
were conducted optimizing reaction conditions (tissue homoge-
nates with protein concentration 2.5 0.2 mg/mI, NADP 200
/LM, 10 minute incubation time, and corticosterone concentra-
tions at or above the calculated Km values), 1 1/3-OHSD activity
remained significantly less in the newborn kidney as compared
to the adult kidney (Table 1). Thus, the differences in enzyme
activity initially observed were due to factors beyond simple
variances in protein concentration.
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Fig. 4. Enzyme kinetics for 1113-OHSD studied in homogenates pre-
pared from renal cortex of newborn (I) and adult (0) animals.
Experiments were conducted in the presence of NADP 200 LM. From
Lineweaver-Burk plots, the apparent Km and Vmax for corticosterone
differs in the two groups. In the newborn: y 4.8150e + 10 + 6170.3x;
r2 = 0.970; Km = 12.8 X 10 M. In the adult: y = 7.5122e + 8 +
3318.8x; r2 = 1.000; Km = 4.42 X 10-6 M; = 1.33 x lO
mol/min/mg protein.
Discussion
Sodium retention is a major requirement for normal postnatal
growth and development [1]. Such positive salt balance is
achieved in the face of limited response to circulating mineral-
ocorticoids in the neonatal period [2, 3]. Various mechanisms
involved with the observed sodium retention have been re-
viewed previously in the literature [11. Although it has received
little attention in this regard, 1 1j3-OHSD may be part of this
adaptive sodium retaining response. When the enzyme is inhib-
ited or deficient, circulating endogenous glucocorticoids exhibit
rnineralocorticoid-like renal sodium retention. There is a grow-
ing body of evidence supporting the view that endogenous
circulating glucocorticoids may induce sodium transport in
Concentration of
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2 x lO M
lO M
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renal tubular epithelial cells either by binding to mineralocorti-
coid or glucocorticoid receptors [13—17]. 1 lf.-OHSD may serve
as a "guardian" over both receptors; the enzyme transforms
the parent glucocorticoid to its respective I 1-dehydro deriva-
tives and prevents binding to a receptor [6, 18]. Thus, the
finding that the newborn kidney exhibits diminished 1 113-OHSD
activity is consistent with a role in sodium conservation. The
low enzyme activity in early life is not restricted to the newborn
rat. Renal 1 1/3-OHSD activity in the rapidly growing piglet,
measured by the percent corticosterone transformed to 11-
dehydrocorticosterone, increases from 55.3 5.0% (N = 6) at
one to three days of life and 50.5 6.4% at one month (N = 5)
to 92.3 1.9% at three months of life (N 4; P < 0.001,
newborn vs. 3 months) [19].
The observed decrease in enzyme activity in the newborn rat
kidney correlates with a lower protein content per gram of
tissue wet weight. However, an absolute deficiency of renal
1 l/3-OHSD during the newborn period can be directly linked to
the immunofluorescent microscopic findings in this study and
the previously reported decrease in the gene message expres-
sion for l1j3-OHSD (inRNA) [20, 21]. Our experiments con-
ducted initially using tissue minces most likely underestimated
differences in enzyme activity as they employed concentrations
of substrate (corticosterone) below the apparent Km values for
both the newborn and adult renal llf3-OHSD which were
calculated later.
Isoforms of this enzyme are located in the S2 and S3
segments of the proximal tubule as well as epithelial cells from
the cortical collecting duct [12, 22]. Interestingly, the different
isoforms of this enzyme appear to have unique biochemical as
well as antigenic characteristics. Antibody derived against liver
1 113-OHSD cross-reacts with this enzyme in proximal renal
tubules, yet fails to recognize the isoform of the enzyme present
in cortical collecting duct cells [12]. In kidneys from newborn
animals, we observed only very limited staining of S2 and S3
proximal tubules with the antibody directed against 1 1/3-OHSD
consistent with the low enzyme activity. As expected, distal
tubule segments did not stain renal cortical samples from the
newborn or from the mature animals.
Additional developmental differences in 1 1/3-OHSD were
noted in enzyme kinetics studies performed on homogenates
prepared from one- to two-day-old rat pup kidneys and mature
rat kidneys. In both the newborn and the mature animal,
1 1f3-OHSD is a very rapid acting enzyme and either NADP or
NAD could be used as a cofactor, as has been previously
reported in the mature rat kidney [23]. The cofactor specificity
is of note since NADP is the preferred cofactor for rat liver
1 1J3-OHSD [24]. NAD is preferred for the 1 1/3-OHSD found in
Table 1. Effect of corticosterone concentration on the generation of
I l-dehydrocorticosterone (Compound A) in kidney homogenates
from newborn and adult rats after a 10 minute incubation (average of
3 values for each point)
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Fig. 3. 11/3-OHSD activity in renal cortex from mature rats as a
function of time. Using corticosterone l0 M, enzyme activity in
homogenates is depicted as the formation of compound A/mm/mg
protein. In both newborn and mature rat renal cortex, the reaction was
rapid and linear from 3 to 10 minutes.
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cultured mammalian distal cortical collecting duct cells [22] and
in toad urinary bladder epithelial cells, a model for a cortical
collecting duct [25].
Perhaps more interesting were the observed differences in the
apparent Km for corticosterone in the newborn and adult rat
kidney. The apparent Km for the adult was calculated to be 4.42
x 10—6 M, a value quite similar to that previously reported [13];
the apparent Km for the newborn was 12.8 X 108 M, a value
closer to that seen in cultured cortical collecting duct cells and
toad bladder [22, 25]. The absence of immunofluorescence
staining for 1 1f3-OHSD in proximal tubular segments and the
observed lower Km are consistent with the view that the
newborn kidney only expresses the "distal isoform" of 11/3-
OHSD with the "proximal isoform" dominating later during
adult life.
Since glucocorticoids appear to play a major role in promot-
ing cell differentiation in cell cultures, decreased 1 l/3-OHSD
activity in the newborn may have additional effects in addition
to sodium conservation. In adapting to extrauterine life, lower
enzyme action could allow circulating glucocorticoids to exert a
greater effect in the maturation of various renal tubule epithelial
cell transport processes [26].
We conclude from the present studies that 11 f3-OHSD activ-
ity is lower in the rat newborn kidney. The decrease in enzyme
activity appears to be due to a lower tissue content of the
enzyme and different enzyme kinetics rather than the presence
of any specific inhibitor. A lower cellular enzyme content and
lower Km would benefit a growing animal by allowing cortico-
sterone, the natural glucocorticoid for a rat, to function as a
sodium retaining hormone, thereby facilitating the renal sodium
conservation needed for growth.
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